Successful Novel Treatment of a Paraspinal Primitive Neuroectodermal Tumor with Predominantly Glial Differentiation: A 3-Year Follow-Up After Surgery, Intensity-Modulated Radiation Therapy and Oral Temozolomide

World Neurosurg. 2018 Nov:119:340-344. doi: 10.1016/j.wneu.2018.07.221. Epub 2018 Aug 1.

Abstract

Background: Paraspinal masses are a relatively uncommon but diverse group of lesions that can be neoplastic or non-neoplastic. Peripheral primitive neuroectodermal tumors of the lumbar paraspinal region with diffuse and strong glial differentiation have never been reported before.

Case description: We report a primary paraspinal primitive neuroectodermal tumor with overwhelming glial differentiation in a 23-year-old female patient who presented with intractable right lower extremity pain. The patient underwent a 2-staged operation with gross total resection of the mass followed by intensity-modulated radiation therapy and oral temozolomide, a regimen employed for high-grade intracranial gliomas. Serial imaging revealed no evidence of recurrence after 3 years.

Conclusions: Although these lesions appear to be exceptionally rare, an approach similar to that of intracranial high-grade glial tumors was effective in our experience. Our patient had no evidence of recurrence at 3-year follow-up.

Keywords: Chemotherapy; High glial differentiation; Paraspinal mass; Paraspinal neoplasm; Paraspinal primitive neuroectodermal tumor; Radiation; Surgery.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / therapy*
  • Female
  • Humans
  • Longitudinal Studies
  • Neuroectodermal Tumors, Primitive / diagnostic imaging
  • Neuroectodermal Tumors, Primitive / therapy*
  • Neuroglia / pathology*
  • Radiotherapy, Intensity-Modulated*
  • Temozolomide / therapeutic use*
  • Tomography Scanners, X-Ray Computed
  • Young Adult

Substances

  • Antineoplastic Agents, Alkylating
  • Temozolomide